Clearmind Medicine Inc — Cash Flow (NASDAQ:CMND) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities —-6.3 M-4.86 M-4.73 M — Cash from investing activities —-26.23 K-238.1 K-542.02 K — Cash from financing activities —11.66 M6.25 M2.62 M — Free cash flow —-6.3 M-4.86 M-4.73 M —

ニュース

Акции Clearmind Medicine падают после обновления данных о безопасности

Clearmind Medicine stock falls after Phase I/IIa trial safety update

Clearmind reports positive safety results in AUD drug trial

Clearmind reports positive safety data from AUD treatment trial

Акции Clearmind Medicine растут после сделки с Polyrizon

Clearmind Medicine stock surges after Polyrizon intranasal delivery deal

Clearmind и Polyrizon разрабатывают интраназальную формулу MEAI

Clearmind partners with Polyrizon to develop intranasal MEAI formulation

Polyrizon разработает интраназальную форму препарата MEAI от Clearmind

Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug

Clearmind восстанавливает соответствие требованиям NASDAQ

Clearmind regains Nasdaq compliance as shares maintain $1 minimum